(Q35994100)

11 August 2017

1 reference

title

Hyperphosphatemia: its consequences and treatment in patients with chronic renal disease (English)

1 reference

11 August 2017

Delmez JA

1

1 reference

11 August 2017

Slatopolsky E

series ordinal

2

1 reference

11 August 2017

publication date

1 April 1992

1 reference

American Journal of Kidney Diseases

11 August 2017

published in

1 reference

11 August 2017

volume

19

1 reference

11 August 2017

issue

4

1 reference

11 August 2017

page(s)

303-317

1 reference

Effect of parathyroid hormone on myocardial energy metabolism in the rat

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Effect of parathyroid hormone on rat heart cells

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Fatty acid oxidation in the myocardium: effects of parathyroid hormone and CRF.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Chronic renal failure, parathyroid hormone and fatty acids oxidation in skeletal muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Verapamil reverses PTH- or CRF-induced abnormal fatty acid oxidation in muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Effect of parathyroid hormone on energy metabolism of skeletal muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Abnormal norepinephrine uptake and release in brain synaptosomes in chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Role of parathyroid hormone in the glucose intolerance of chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Insulin release from pancreatic islets: effects of CRF and excess PTH.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Effect of parathyroid hormone on erythropoiesis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Effect of Parathyroid Hormone on Osmotic Fragility of Human Erythrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Calcific Cardiomyopathy in Advanced Renal Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Myocardial calcification and cardiac dysfunction in chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Disordered calcium and phosphorus metabolism during maintenance hemodialysis. Correlation of clinical, roentgenographic and biochemical changes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Soft tissue calcification in pediatric patients with end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Phosphate excess and progressive renal failure: the precipitation-calcification hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Oral intake of phosphorus can determine the serum concentration of 1,25-dihydroxyvitamin D by determining its production rate in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Dietary Phosphate Deprivation in Women and Men: Effects on Mineral and Acid Balances, Parathyroid Hormone and the Metabolism of 25-OH-Vitamin D*

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

The role of phosphate in the secretion of parathyroid hormone in man

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Bone and soft tissue changes with oral phosphate supplements

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Long-Term Effects of High Phosphate Intake on Parathyroid Hormone Levels and Bone Metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

On the pathogenesis of hyperparathyroidism in chronic experimental renal insufficiency in the dog

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

The role of phosphorus restriction in the prevention of secondary hyperparathyroidism in chronic renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Determinants of serum 1,25(OH)2D levels in renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Calcium Metabolism in Early Chronic Renal Failure: Implications for the Pathogenesis of Hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Hyperparathyroidism and 1,25-Dihydroxyvitamin D Deficiency in Mild, Moderate, and Severe Renal Failure*

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Study of intestinal absorption of calcium in patients with renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Bone histology in incipient and advanced renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

On the mechanism of secondary hyperparathyroidism in moderate renal insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Regulation by vitamin D metabolites of messenger ribonucleic acid for preproparathyroid hormone in isolated bovine parathyroid cells

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

1,25-Dihydroxyvitamin D3 suppresses parathyroid hormone secretion from bovine parathyroid cells in tissue culture

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Suppression by 1,25(OH)2D3 of transcription of the pre-proparathyroid hormone gene

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Decrease in serum immunoreactive parathyroid hormone in rats and in parathyroid hormone secretion in vitro by 1,25-dihydroxycholecalciferol

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

How Important Is Phosphate in the Pathogenesis of Renal Osteodystrophy?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Hypocalcemia may not be essential for the development of secondary hyperparathyroidism in chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Effects of dietary protein and phosphorus restriction on the progression of early renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Reversal of hyperparathyroidism in severe uremics following very low-protein and low-phosphorus diet

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

The short-term effects of a low-protein diet in stable renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Effect of energy intake on nitrogen metabolism in nondialyzed patients with chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

A mechanistic analysis of the National Cooperative Dialysis Study (NCDS)

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Assessing the adequacy of dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Metabolic balance studies and dietary protein requirements in patients undergoing continuous ambulatory peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Calcium and phosphorus fluxes during hemodialysis with low calcium dialysate

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Improved phosphate clearances with polycarbonate membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Performance characteristics of the hemoflow F 60 in high-flux hemodiafiltration

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Effect of hematocrit on solute removal during high efficiency hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Minerals, vitamin D, and parathyroid hormone in continuous ambulatory peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

The Effect of Aluminium Hydroxide on Calcium, Phosphorus and Aluminium Balances, the Serum Parathyroid Hormone Concentration and the Aluminium Content of Bone in Patients with Chronic Renal Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Aluminium toxicity during regular haemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Composition of the domestic water supply and the incidence of fractures and encephalopathy in patients on home dialysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Does Strict Phosphorus Control Precipitate Renal Osteomalacia*

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Effect of parathyroidectomy on bone aluminum accumulation in chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Residual renal function in hemodialysis patients may protect against hyperaluminemia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Early deposition of aluminum in bone in diabetic patients on hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Aluminum accumulation during treatment with aluminum hydroxide and dialysis in children and young adults with chronic renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

The influence of a high calcium carbonate intake on bone disease in patients undergoing hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Effects of oral calcium carbonate on control of serum phosphorus and changes in plasma aluminum levels after discontinuation of aluminum-containing gels in children receiving dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

The use of calcium carbonate to treat the hyperphosphataemia of chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Calcium carbonate as a phosphate binder in patients with chronic renal failure undergoing dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Long-term effects of calcium carbonate and 2.5 mEq/liter calcium dialysate on mineral metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Etiology of hypercalcemia in hemodialysis patients on calcium carbonate therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Role of vitamin D-dependent and vitamin D-independent mechanisms in absorption of food calcium

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Reduction of dietary phosphorus absorption by phosphorus binders. A theoretical, in vitro, and in vivo study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Calcium acetate, an effective phosphorus binder in patients with renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Calcium acetate control of serum phosphorus in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Long-term administration of calcium acetate efficiently controls severe hyperphosphataemia in haemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

The Treatment of Uraemic Hyperphosphataemia with Calcium Acetate and Calcium Carbonate: A Comparative Study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Calcium citrate, a nonaluminum-containing phosphate-binding agent for treatment of CRF

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Calcium citrate markedly enhances aluminum absorption from aluminum hydroxide

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Influence of calcium acetate or calcium citrate on intestinal aluminum absorption

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Site and mechanism of enhanced gastrointestinal absorption of aluminum by citrate

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Intestinal absorption of magnesium from food and supplements

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Substitution of aluminium salts by magnesium salts in control of dialysis hyperphosphataemia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Effects of a magnesium-free dialysate on magnesium metabolism during continuous ambulatory peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

The use of magnesium-containing phosphate binders in patients with end-stage renal disease on maintenance hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Magnesium hydroxide as a complementary aluminium-free phosphate binder to moderate doses of oral calcium in uraemic patients on chronic haemodialysis: lack of deleterious effect on bone mineralisation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Treatment compliance in end-stage renal disease patients on dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Effect of the time of administration of calcium acetate on phosphorus binding.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D. A role for increased sensitivity to calcium

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Direct inhibitory effect of calcitriol on parathyroid function (sigmoidal curve) in dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

1,25(OH)2 vitamin D3 inhibits parathyroid cell proliferation in experimental uremia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

The noncalcemic analogue of vitamin D, 22-oxacalcitriol, suppresses parathyroid hormone synthesis and secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

A hypothesis: the protein catabolic rate is dependent upon the type and amount of treatment in dialyzed uremic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980446-X

7 January 2021

10.1016/S0272-6386(12)80446-X

Identifiers

DOI

1 reference

11 August 2017

1 reference